Corona Virus Disease 2019 Cohort Study

NCT ID: NCT06927622

Last Updated: 2025-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-01

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about the influence of Corona Virus Disease 2019 on obstetric outcome and offspring development.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main questions it aims to answer are:

* Collect the information about Corona Virus Disease 2019 infection and medication of pregnant women to establish a birth cohort, and analyze the correlation between Corona Virus Disease 2019 infection during pregnancy and adverse pregnancy outcomes and birth outcomes.
* The offspring born in this cohort were followed up to analyze the effects of Corona Virus Disease 2019 infection during pregnancy on the nervous system development of the offspring.

Researchers will compare Corona Virus Disease 2019 infection group and uninfected group during pregnancy to see if Corona Virus Disease 2019 infection has adverse effects on pregnant women and their offspring.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Pneumonia COVID-19 Pandemic COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Conduct regular prenatal examinations in the hospital and establish a pregnancy and childbirth health manual, planning for pregnant women who are hospitalized for delivery;
* Conduct regular physical examinations in the hospital and establish a children's health manual for infants.
* Age ≥ 18 years old

Exclusion Criteria

* Concomitant tumor related diseases;
* Individuals with severe mental disorders.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Qilu Hospital of Shandong University

OTHER

Sponsor Role collaborator

Jinan Maternity and Child Health Care Hospital

UNKNOWN

Sponsor Role collaborator

Shandong Provincial Maternity and Child Health Care Hospital

UNKNOWN

Sponsor Role collaborator

The Second Hospital of Shandong University

OTHER

Sponsor Role collaborator

Qianfoshan Hospital

OTHER

Sponsor Role collaborator

Shandong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yinuo Song

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fanzhen Hong, Doctorate

Role: STUDY_DIRECTOR

The Second Hospital of Shandong University

Xia Luo, Doctorate

Role: STUDY_DIRECTOR

Qilu Hospital of Shandong University

Yueqin Xu, Doctorate

Role: STUDY_DIRECTOR

Qianfoshan Hospital

Qiuhong Yang, Doctorate

Role: STUDY_DIRECTOR

Jinan Maternity and Child Health Care Hospital

Jie Chen, Doctorate

Role: STUDY_CHAIR

Shandong University

Yinuo Song, Master

Role: PRINCIPAL_INVESTIGATOR

Shandong University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Second Hospital of Shandong University

Jinan, Shandong, China

Site Status RECRUITING

Jinan Maternity and Child Health Care Hospital

Jinan, , China

Site Status RECRUITING

Qianfoshan Hospital

Jinan, , China

Site Status RECRUITING

Qilu Hospital of Shandong University

Jinan, , China

Site Status RECRUITING

Shandong Provincial Maternity and Child Health Care Hospital

Jinan, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jie Chen, Doctorate

Role: CONTACT

18615656606 ext. 86

Yinuo Song

Role: CONTACT

17861203953 ext. 86

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yinuo Song, Master

Role: primary

17861203953 ext. 86

Yinuo Song, Master

Role: primary

17861203953 ext. 86

Yinuo Song, Master

Role: primary

17861203953 ext. 86

Yinuo Song, Master

Role: primary

17861203953 ext. 86

Yinuo Song, Master

Role: primary

17861203953 ext. 86

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LL202303018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Northeast COVID-19 and Pregnancy Study Group
NCT04462367 ACTIVE_NOT_RECRUITING